127 related articles for article (PubMed ID: 2197510)
1. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts.
Alitalo R
Leuk Res; 1990; 14(6):501-14. PubMed ID: 2197510
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
3. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
Yen A; Varvayanis S; Platko JD
Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
[TBL] [Abstract][Full Text] [Related]
4. Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-O1.
Murate T; Hotta T; Tsushita K; Suzuki M; Yoshida T; Saga S; Saito H; Yoshida S
Blood; 1991 Dec; 78(12):3168-77. PubMed ID: 1742484
[TBL] [Abstract][Full Text] [Related]
5. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
Chou CC; Yung BY; Hsu CY
Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
[TBL] [Abstract][Full Text] [Related]
7. Induction of platelet-derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines.
Alitalo R; Andersson LC; Betsholtz C; Nilsson K; Westermark B; Heldin CH; Alitalo K
EMBO J; 1987 May; 6(5):1213-8. PubMed ID: 3475202
[TBL] [Abstract][Full Text] [Related]
8. Co-ordinate expression of activin A and its type I receptor mRNAs during phorbol ester-induced differentiation of human K562 erythroleukemia cells.
Hildén K; Tuuri T; Erämaa M; Ritvos O
Mol Cell Endocrinol; 1999 Jul; 153(1-2):137-45. PubMed ID: 10459861
[TBL] [Abstract][Full Text] [Related]
9. [Chemical control of cell differentiation of human myeloleukemia K562 cell line].
Koiso Y; Nakajima O; Matsumura D; Fujimoto Y; Hashimoto Y
Yakugaku Zasshi; 2000 Jan; 120(1):104-12. PubMed ID: 10655786
[TBL] [Abstract][Full Text] [Related]
10. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of transforming growth factor beta during megakaryoblastic differentiation of K562 leukemia cells.
Alitalo R; Mäkelä TP; Koskinen P; Andersson LC; Alitalo K
Blood; 1988 Apr; 71(4):899-906. PubMed ID: 3162693
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of an essential, activating regulatory element of the human SIS/PDGFB promoter in human megakaryocytes.
Jin HM; Brady ML; Fahl WE
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7563-7. PubMed ID: 8356057
[TBL] [Abstract][Full Text] [Related]
13. Gene expression during phorbol ester-induced differentiation of cultured human megakaryoblastic cells.
Dorn GW; Davis MG; D'Angelo DD
Am J Physiol; 1994 May; 266(5 Pt 1):C1231-9. PubMed ID: 8203487
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GM3 can induce megakaryocytoid differentiation of human leukemia cell line K562 cells.
Nakamura M; Kirito K; Yamanoi J; Wainai T; Nojiri H; Saito M
Cancer Res; 1991 Apr; 51(7):1940-5. PubMed ID: 2004380
[TBL] [Abstract][Full Text] [Related]
15. Regulation of c-myc mRNA decay in vitro by a phorbol ester-inducible, ribosome-associated component in differentiating megakaryoblasts.
Brewer G
J Biol Chem; 2000 Oct; 275(43):33336-45. PubMed ID: 10931849
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
[TBL] [Abstract][Full Text] [Related]
17. Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells.
Tetteroo PA; Massaro F; Mulder A; Schreuder-van Gelder R; von dem Borne AE
Leuk Res; 1984; 8(2):197-206. PubMed ID: 6232432
[TBL] [Abstract][Full Text] [Related]
18. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.
Colosetti P; Puissant A; Robert G; Luciano F; Jacquel A; Gounon P; Cassuto JP; Auberger P
Autophagy; 2009 Nov; 5(8):1092-8. PubMed ID: 19786835
[TBL] [Abstract][Full Text] [Related]
19. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
20. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
